2361 Stock Overview
Sinohealth Holdings Limited provides healthcare insight solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally.
Sinohealth Holdings Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$2.41|
|52 Week High||HK$7.11|
|52 Week Low||HK$2.00|
|1 Month Change||-26.30%|
|3 Month Change||-27.84%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-55.04%|
Recent News & Updates
|2361||HK Healthcare Services||HK Market|
Return vs Industry: Insufficient data to determine how 2361 performed against the Hong Kong Healthcare Services industry.
Return vs Market: Insufficient data to determine how 2361 performed against the Hong Kong Market.
|2361 Average Weekly Movement||12.4%|
|Healthcare Services Industry Average Movement||11.4%|
|Market Average Movement||8.0%|
|10% most volatile stocks in HK Market||15.0%|
|10% least volatile stocks in HK Market||4.0%|
Stable Share Price: 2361 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: Insufficient data to determine 2361's volatility change over the past year.
About the Company
Sinohealth Holdings Limited provides healthcare insight solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally. It offers business growth or investment solutions in the form of customized data insights report to help clients make their business decisions and data-driven marketing solutions for promotion of clients’ products to retail pharmacies and consumers. The company also provides publications in the form of speeches, reports, or presentations; precision connections, including brand promotion campaigns, roadshows, or one-on-one business meetings targeting to business partners and investors, as well as organizes and hosts exhibitions for the healthcare industry participants.
Sinohealth Holdings Limited Fundamentals Summary
|2361 fundamental statistics|
Is 2361 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|2361 income statement (TTM)|
|Cost of Revenue||CN¥151.11m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.15|
|Net Profit Margin||19.43%|
How did 2361 perform over the long term?See historical performance and comparison